Zimmer Biomet has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its ROSA ONE Spine System in robotically assisted surgeries.
The company’s craniomaxillofacial (CMF) and thoracic and surgery assisting technology group president Aure Bruneau said: “ROSA ONE Spine functions as a dual robotics and navigation technology solution for minimally invasive and complex thoracolumbar spine procedures.”
ROSA ONE Spine’s surgical navigation system features a real-time patient tracking capability and 3D intra-operative planning software for improved implant placement.
The new device expands the company’s suite of ROSA ONE systems, offers treatment of neurosurgical, spinal and knee pathologies in one platform.
The FDA cleared ROSA ONE Knee in January this year for use in robotically assisted total knee replacements. This device features 3D pre-operative planning tools and real-time, intraoperative data on soft-tissue and bone anatomy.
The knee surgery device is intended to improve bone cut accuracy and a range of motion gap analyses to potentially boost flexion and restore natural joint movement.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
ROSA ONE Brain received US regulatory clearance in February for neurosurgical minimally invasive procedures such as biopsies and deep brain stimulation.
In addition to surgical systems, Zimmer Biomet portfolio includes orthopaedic reconstructive, sports medicine, extremities and trauma products, among other medical devices.